Literature DB >> 12192308

Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.

Y Emori1, M Sakugawa, K Niiya, T Kiguchi, K Kojima, K Takenaka, K Shinagawa, F Ishimaru, K Ikeda, M Tanimoto, R Yamasaki, N Ohara, M Harada.   

Abstract

Acquired factor X deficiency has been described in patients with amyloidosis but acquired factor V deficiency is quite rare. We report here a case of life-threatening bleeding and acquired factor V deficiency associated with primary amyloidosis. A 50-year-old man who had no previous hemorrhagic diathesis was referred to our hospital because of recurrent epistaxis, gingival bleeding and hemospermia. The laboratory examination revealed that both the prothrombin time (PT) and the activated partial thromboplastin time (aPTT) were significantly prolonged, and factor V activities were markedly decreased to 14-39% of the normal value. Other coagulation factors such as fibrinogen, prothrombin, factor VII, factor VIII, factor IX and factor X were subnormal and normal. Transaminases were slightly elevated but serological tests of hepatitis B and hepatitis C were negative. Mild hepatosplenomegaly was noted without sign of liver cirrhosis. The PT and aPTT obtained 8 years ago when he received a cholecystectomy due to cholecystitis were both normal. Specific assays for the detection of factor V inhibitor were repeatedly performed but no factor V inhibitor was found. Furthermore, a significant recovery of the infused factor V was noted shortly after an intravenous administration of 5-10 U fresh frozen plasma, but it did not last more than 6 h. Melena, bleedings into the left shoulder and buttock, and finally mortal retroperitoneal hemorrhage developed despite repeated infusions of large amounts of fresh frozen plasma. Acquired factor V deficiency associated with primary amyloidosis was suspected but histological diagnosis was not obtained because of the severe bleeding tendency. Autopsy revealed hepatosplenomegaly and massive deposits of AL amyloid in the liver, spleen, heart and other parenchymal organs. Perivascular amyloid deposition and factor V deficiency are both thought to be the cause of the severe hemorrhagic tendency seen in this patient.

Entities:  

Mesh:

Year:  2002        PMID: 12192308     DOI: 10.1097/00001721-200209000-00011

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Acquired factor V deficiency in a patient without evidence of a classical inhibitor.

Authors:  I R Sosa; P Ellery; A Mast; A T Neff; D Gailani
Journal:  Haemophilia       Date:  2013-10-14       Impact factor: 4.287

Review 3.  Hematospermia-a Symptom With Many Possible Causes.

Authors:  Michael J Mathers; Stefan Degener; Herbert Sperling; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2017-03-17       Impact factor: 5.594

Review 4.  Amyloid in surgical pathology.

Authors:  Christoph Röcken; Knut Sletten
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

5.  Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.

Authors:  Qing-ya Cui; Hong-shi Shen; Tian-qin Wu; Hai-fei Chen; Zi-qiang Yu; Zhao-yue Wang
Journal:  Drug Des Devel Ther       Date:  2015-04-24       Impact factor: 4.162

6.  [Primary light chain amyloidosis onset with acquired FX deficiency: a case report and literature review].

Authors:  C Wei; J Feng; T N Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

7.  Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.

Authors:  Anthony L Nguyen; Muhammad Kamal; Ravi Raghavan; Gayathri Nagaraj
Journal:  Hematol Rep       Date:  2018-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.